Early‐acting cytokine‐driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post‐mitotic offspring with preserved engraftment ability in non‐obese diabetic/severe combined immunodeficient mice
Open Access
- 1 September 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 114 (4) , 920-930
- https://doi.org/10.1046/j.1365-2141.2001.02974.x
Abstract
The ability of ex‐vivo expanded peripheral blood stem cells (PBSC) to engraft non‐obese diabetic/severe combined immunodeficient (NOD/SCID) mice has not been evaluated to date. We investigated the maintenance of primitive SCID‐repopulating cells (SRC) and long‐term culture‐initiating cells (LTCIC) in PBSC expanded with early‐acting cytokines, thrombopoietin (TPO), stem cell factor (SCF) and FlT3‐ligand (FL) with or without interleukin 3 (IL‐3) and IL‐6 in short‐term (6 d) stroma‐free serum‐free cultures. TPO + SCF + FL and TPO + SCF + FL + IL‐3 + IL‐6 produced 5·9 ± 1·97 and 18·25 ± 4·49 (mean ± SEM)‐fold increase of CD34+ cells respectively. We tracked cellular division with PKH26 and sorted post‐mitotic CD34+ PKH26low cells to assess their primitive functional properties. After culture with TPO + SCF + FL, LTCICs among post‐mitotic cells increased 12·08 ± 3·4 times, and 4·3 ± 1·6 times when IL‐3 + IL‐6 were added. CD34+ PKH26low cells cultured with TPO + SCF + FL provided human multilineage (CD34, CD33 and CD19) engraftment in NOD/SCID mice, whereas no human cells were detected in mice injected with cells cultured with TPO + SCF + FL + IL‐3 + IL‐6. Percentages of CD34+/CD38, CD34+/CD33, CD34+/DR and cells in G0/G1 phase were similar among cells cultured with both cytokine combinations, indicating that the deleterious impact of IL‐3 + IL‐6 on the ability to engraft is not translated into phenotypic or cycling features. In conclusion, TPO + SCF + FL‐expanded PBSC maintain multilineage engraftment ability in NOD/SCID mice, which is abrogated by the addition of IL‐3 + IL‐6.Keywords
This publication has 41 references indexed in Scilit:
- Direct Evidence for Multiple Self-Renewal Divisions of Human In Vivo Repopulating Hematopoietic Cells in Short-Term CultureBlood, 1999
- Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cellsThe Lancet, 1999
- Hematopoietic stem cell expansionTransfusion Science, 1997
- CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimensBone Marrow Transplantation, 1997
- Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.The Journal of Experimental Medicine, 1996
- Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells.Proceedings of the National Academy of Sciences, 1996
- Long-term Hematopoietic Culture-initiating Cells Are More Abundant in Mobilized Peripheral Blood Grafts Than in Bone Marrow but Have a More Limited Ex Vivo Expansion PotentialBlood Cells, Molecules, and Diseases, 1996
- Bone marrow transplantation across HLA barriers by increasing the number of transplanted cellsImmunology Today, 1995
- Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex VivoNew England Journal of Medicine, 1995
- Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.Proceedings of the National Academy of Sciences, 1992